sodium iodide(131I) - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
ANSTO Health Sodium Iodide(131I) 200MBq/mL injection multidose vial
AUST R: 22800
Active ingredients:
sodium iodide(131I)

Dosage form:
Injection, solution

Sponsor:
Australian Nuclear Science and Technology Organisation T/A ANSTO

Phone:
1800251572

From
08 Apr 2019
to
31 Aug 2021

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

AUSTRALIAN RADIOISOTOPES Sodium Iodide (I-131) 50 - 6000MBq Therapy Capsule vial
AUST R: 22808
Active ingredients:
sodium iodide(131I)

Dosage form:
Capsule, hard

Sponsor:
Australian Nuclear Science and Technology Organisation T/A ANSTO

Phone:
1800251572

From
09 Sep 2021
to
18 Oct 2021

Shortage status:
Anticipated

Availability:
Available

Reason:
Manufacturing

Management action:
During the period from 09 September to 01 October 2021, limited supply of the I-131 products will be available to customers. To ensure minimal impact, ANSTO has been in consultation with the nuclear medicine working group to optimise the activity and the size of the product during the period of limited supply (from 09 Sep-01 October).
For the period from 02 Oct to 18 October 2021, I-131 products won't be available for supply from ANSTO. It is estimated that ANSTO won’t be able to supply the Australian Domestic Market with approximately 200,000MBq or about 165 patient doses of Iodine-131 Capsules.

Sodium iodide(131I) 2000MBq/mL Therapy Solution oral liquid BP vial
AUST R: 48267
Active ingredients:
sodium iodide(131I)

Dosage form:
Oral Liquid, solution

Sponsor:
Australian Nuclear Science and Technology Organisation T/A ANSTO

Phone:
1800251572

From
09 Sep 2021
to
18 Oct 2021

Shortage status:
Anticipated

Availability:
Available

Reason:
Manufacturing

Management action:
During the period from 09 September to 01 October 2021, limited supply of the I-131 products will be available to customers. To ensure minimal impact, ANSTO has been in consultation with the nuclear medicine working group to optimise the activity and the size of the product during the period of limited supply (from 09 Sep-01 October).
For the period from 02 Oct to 18 October 2021, I-131 products won't be available for supply from ANSTO. It is estimated that ANSTO won’t be able to supply the Australian Domestic Market with approximately 11,400MBq of Iodine-131 Solution (2000MBq/mL size solution product).

Sodium iodide(131I) 200MBq/mL Therapy Solution oral liquid BP vial
AUST R: 22807
Active ingredients:
sodium iodide(131I)

Dosage form:
Oral Liquid, solution

Sponsor:
Australian Nuclear Science and Technology Organisation T/A ANSTO

Phone:
1800251572

From
09 Sep 2021
to
18 Oct 2021

Shortage status:
Anticipated

Availability:
Available

Reason:
Manufacturing

Management action:
During the period from 09 September to 01 October 2021, limited supply of the I-131 products will be available to customers. To ensure minimal impact, ANSTO has been in consultation with the nuclear medicine working group to optimise the activity and the size of the product during the period of limited supply (from 09 Sep-01 October).
For the period from 02 Oct to 18 October 2021, I-131 products won't be available for supply from ANSTO. It is estimated that ANSTO won’t be able to supply the Australian Domestic Market with approximately 10,000MBq of Iodine-131 Solution (200MBq/mL size solution product).